420
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitis

, , , , &
Pages 1433-1441 | Accepted 22 Mar 2010, Published online: 15 Apr 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

A. Kolumbic Lakos, V. Skerk, G.- Malekovic, T. Dujnic Spoljarevic, D. Kovacic, M. Pasini, A.- Markotic, V.- Magri & G. Perletti. (2011) A Switch Therapy Protocol with Intravenous Azithromycin and Ciprofloxacin Combination for Severe, Relapsing Chronic Bacterial Prostatitis: a Prospective Non-Comparative Pilot Study. Journal of Chemotherapy 23:6, pages 350-353.
Read now

Articles from other publishers (7)

Tyler J. Brehm, Barbara W. Trautner & Prathit A. Kulkarni. (2023) Acute and Chronic Infectious Prostatitis in Older Adults. Infectious Disease Clinics of North America 37:1, pages 175-194.
Crossref
John C. Lam, Raynell Lang & William Stokes. (2023) How I manage bacterial prostatitis. Clinical Microbiology and Infection 29:1, pages 32-37.
Crossref
Zhuo Tony Su, Jonathan Mark Zenilman, Karen Sandell Sfanos & Amin Sedaghat Herati. (2020) Management of Chronic Bacterial Prostatitis. Current Urology Reports 21:7.
Crossref
Anthony J. Schaeffer & Lindsay E. Nicolle. (2016) Urinary Tract Infections in Older Men. New England Journal of Medicine 374:6, pages 562-571.
Crossref
Gianpaolo Perletti, Emanuela Marras, Florian ME Wagenlehner & Vittorio Magri. (2013) Antimicrobial therapy for chronic bacterial prostatitis. Cochrane Database of Systematic Reviews.
Crossref
Zhi-Chao Zhang, Feng-Shuo Jin, Dong-Ming Liu, Zhou-Jun Shen, Ying-Hao Sun & Ying-Lu Guo. (2012) Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic bacterial prostatitis in Chinese patients. Asian Journal of Andrology 14:6, pages 870-874.
Crossref
Y.-H. Chen, W.-C. Ko & P.-R. Hsueh. (2011) The role of fluoroquinolones in the management of urinary tract infections in areas with high rates of fluoroquinolone-resistant uropathogens. European Journal of Clinical Microbiology & Infectious Diseases 31:8, pages 1699-1704.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.